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Abstract
Background: Dioxins and related compounds are suspected of causing neurological disruption.
Epidemiological studies indicated that exposure to these compounds caused neurodevelopmental
disturbances such as learning disability and attention deficit hyperactivity disorder, which are
thought to be closely related to dopaminergic dysfunction. Although the molecular mechanism of
their actions has not been fully investigated, a major participant in the process is aryl hydrocarbon
receptor (AhR). This study focused on the effect of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)
exposure on the regulation of TH, a rate-limiting enzyme of dopamine synthesis, gene expression
by AhR.
Methods: N2a-Rβ cells were established by transfecting murine neuroblastoma Neuro2a with the
rat AhR cDNA. TH expression induced by TCDD was assessed by RT-PCR and Western blotting.
Participation of AhR in TCDD-induced TH gene expression was confirmed by suppressing AhR
expression using the siRNA method. Catecholamines including dopamine were measured by high-
performance liquid chromatography. A reporter gene assay was used to identify regulatory motifs
in the promoter region of TH gene. Binding of AhR with the regulatory motif was confirmed by an
electrophoretic mobility shift assay (EMSA).
Results: Induction of TH by TCDD through AhR activation was detected at mRNA and protein
levels. Induced TH protein was functional and its expression increased dopamine synthesis. The
reporter gene assay and EMSA indicated that AhR directly regulated TH gene expression.
Regulatory sequence called aryl hydrocarbon receptor responsive element III (AHRE-III) was
identified upstream of the TH gene from -285 bp to -167 bp. Under TCDD exposure, an AhR
complex was bound to AHRE-III as well as the xenobiotic response element (XRE), though AHRE-
III was not identical to XRE, the conventional AhR-binding motif.
Conclusion: Our results suggest TCDD directly regulate the dopamine system by TH gene
transactivation via an AhR-AHRE-III-mediated pathway. The AhR- mediated pathway could have a
particular AhR-mediated genomic control pathway transmitting the effects of TCDD action to
target cells in the development of dopaminergic disabilities.
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Background
Halogenated aromatic hydrocarbons (HAHs) such as
polychlorinated biphenyls (PCBs) and poly-chlorod-
ibenzo-p-dioxins (PCDDs) affect human health when
they are absorbed by the body. Their effects are predomi-
nantly negative, such as oncogenesis, reproductive toxic-
ity, immunosuppression, and neurological dysfunction
[1-4]. One of the dioxins, 2, 3, 7, 8-tetrachlorodibenzo-p-
dioxin (TCDD), leads to neurobehavioral abnormalities
associated with both cognitive and locomotor systems
[5,6]. While the precise anatomical regions and cell types
targeted by TCDD are largely unidentified, the functional
abnormalities may be consistent with findings of
improper brain maturation in epidemiological and exper-
imental animal studies. Experimental animal studies have
indicated that perinatal exposure to TCDD has a marked
effect on learning ability in rats and monkeys [7-9]. Epide-
miological studies have suggested that children acciden-
tally exposed to PCB and dioxins exhibit delayed motor
development and show a tendency to hyperactivity [10].
Another report has indicated an association of serum con-
centrations of dioxins with the prevalence of learning dis-
ability and attention deficit hyperactivity disorder
(ADHD) [11]. However, the precise mechanisms of
TCDD action in the brain have not been fully elucidated.
A major participant in the process of dioxin toxicity is the
aryl hydrocarbon receptor (AhR) [12,13]. AhR is a ligand-
activated transcription factor belonging to the basic helix-
loop-helix/Per-Arnt-Sim (bHLH-PAS) transcription factor
superfamily [14,15]. Dioxins and PCBs, which are the
major ligands of AhR, bind and activate it. The ligand-acti-
vated AhR translocates into the nucleus with the aryl
hydrocarbon receptor nuclear translocator (ARNT), and
binds to the xenobiotic response element (XRE) on the
target gene enhancer, thereby activating gene expression
[16,17]. The genes of many xenobiotic-metabolizing
enzymes possess XRE and are activated by the AhR-ARNT
complex. Phase I enzymes including cytochrome P450
CYP1A1 or CYP1B1 and phase II enzymes such as glutath-
ione S-transferase (GST), metabolize xenobiotics in the
process of detoxification [18-21].
Whereas our understanding of the molecular mechanisms
by which TCDD modulates gene regulation is progressing,
results reported on the neurotoxicity of AhR are not fully
consistent with the current understanding. TCDD has
been recently shown to induce CYP1A1 mRNA and pro-
tein via the AhR-ARNT complex in granule cells of the rat
cerebellum [22]. Although AhR is expressed in various
regions of the brain, CYP1A1 expression in response to
TCDD has been observed in a few brain cells, and the
expression of phase II enzymes such as GST in response to
TCDD has not been observed in any region [23,24]. It is
difficult to explain AhR-mediated neurotoxicity in
response to TCDD or related HAHs based only on the pre-
viously reported molecular mechanisms. There may also
be mechanisms that are independent of xenobiotic
metabolism and detoxification. Molecular mechanisms
connecting AhR-mediated gene expression in neuronal
cells and TCDD-induced neurotoxic effects, including
behavioral abnormalities, should therefore be explored.
We have attempted to identify a target gene of AhR-medi-
ated neurotoxicity in neurons. To analyze the relationship
between AhR activation and neurotoxicity in a previous
study, we stably transfected cells of the murine neuroblas-
toma cell line, Neuro2a, with AhR cDNA to produce N2a-
R cells. These cells exhibited overexpression and func-
tional activation of AhR. Using N2a-R cells, we demon-
strated that tyrosine hydroxylase (TH) mRNA level
increased and that this increase correlated to AhR activa-
tion [25].
TH is the rate-limiting enzyme of dopamine synthesis and
a selective marker of catecholaminergic neurons [26].
Because abnormal expression of TH is related to
dopaminergic dysfunction such as in Parkinson's disease
[27], TH may be a key molecule in dopaminergic func-
tion. According to epidemiological and experimental ani-
mal studies, dioxins and related HAHs are potentially able
to induce hyperactivity and learning disability [9,10].
Behavioral abnormalities including ADHD are thought to
be closely related to dopaminergic neural function. Evi-
dence supporting dopaminergic dysfunction in ADHD
derives from three research areas: the neuropharmacology
of stimulant medication [28], the behavior and biochem-
istry of animal models [29], and neuroimaging studies in
adults with ADHD [30,31]. Many molecular genetic stud-
ies have focused on genes participating in the dopamine
system. TH is hyperexpressed in the Naples high-excitabil-
ity (NHE) rat, which shows behavioral traits resembling
the main aspects of ADHD in humans [32,33]. If behavio-
ral abnormalities induced by TCDD are attributable to
dopaminergic dysfunction, TH is an important candidate
for a key molecule of TCDD-induced neurotoxic effects. In
fact, another study has shown that the level of dopamine
was associated with subchronic exposure of TCDD in rats
[34]. Although overproduction of dopamine in the hip-
pocampus and brainstem was observed in rats exposed to
TCDD, there is no direct evidence indicating that the acti-
vation of AhR by TCDD causes abnormal activation of
dopamine synthesis.
In the present study, we analyzed the regulation of the TH
gene by TCDD-activated AhR. It will help in the develop-
ment of treatment to prevent behavioral abnormality
caused by exogenous chemicals. We describe the tran-Environmental Health 2009, 8:24 http://www.ehjournal.net/content/8/1/24
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scriptional activation of the TH gene depending on the
AhR differing from the generally recognized XRE-medi-
ated pathway.
Methods
Dioxin treatment
TCDD was purchased from Kanto Chemical (Tokyo,
Japan) and was maintained as a stock solution (50 μg/ml)
in dimethyl sulfoxide (DMSO). Cells were treated by add-
ing TCDD to the culture medium.
Cell cultures
Neuro2a, a murine neuroblastoma cell line, was pur-
chased from the American Type Culture Collection. Sev-
eral N2a-R cell lines were established by transfecting
Neuro2a cells with the rat AhR cDNA, as previously
reported [25]. N2a-Rα and N2a-Rβ are clones obtained
during the establishment of Neuro2a cell lines and are
maintained as stable transfectants. The N2a-Vc cell line
was also established by transfecting Neuro2a cells with an
intact vector [25]. These cells were routinely grown in Dul-
becco's modified Eagle's medium and medium F12 in a
1:1 ratio, supplemented with 10% fetal calf serum. Cells
were grown at 37°C in a humidified atmosphere of 5%
CO2/95% air.
Western blot analysis
Cells were collected and homogenized in phosphate-buff-
ered saline. Total protein concentrations were determined
using the Bio-Rad protein assay (Bio-Rad Laboratories Inc,
California, USA). Proteins (30 μg/lane) were separated on
10% SDS-PAGE and transferred to PVDF membranes
(Millipore, Massachusetts, USA). Membranes were
blocked with Block Ace (Dainippon Seiyaku, Osaka,
Japan) and incubated with primary antibody. AhR and TH
were detected using an anti-AhR mouse monoclonal anti-
body (1:500; Affinity BioReagents, Colorado, USA) and
an anti-TH mouse monoclonal antibody (1:500; Affinity
BioReagents), respectively. After incubation with the pri-
mary antibody, the membranes were washed three times
with Tris-buffered saline (TBS) and incubated with a rab-
bit alkaline phosphatase-conjugated anti-mouse IgG
(1:1000; Bio-Rad Laboratories Inc.). The blots were visu-
alized with BCIP-NBT substrate solution (Kirkegaard &
Perry Laboratories, Inc., Maryland, USA).
Reverse transcription: RT-PCR
Total RNA was isolated from the cells using RNeasy (QIA-
GEN, Hilden, Germany) and reverse transcribed with
Superscript II reverse transcriptase (Invitrogen, California
USA). PCR was performed with Ex Taq polymerase
(Takara Bio Inc., Shiga, Japan) using the following prim-
ers: AhR, 5'-CCGTCCATCCTGGAAATTCGAACC-3' and
5'-CCTTCTTCATCCGTTAGCGGTCTC-3'; TH, 5'-CCACG-
GTGTACTGGTTCACT-3' and 5'-GGCATAGTTCCTGAG
CTTGT-3'; CYP1A1, 5'-TTGCCCTTCATTGGTCACAT-3'
and 5'-GAGCAGCTCTTGGTCATCAT-3'; and cyclophilin,
5'-GTCTCCTTCGAGCTGTTTGCAG-3' and 5'-CCATC-
CAGCCATTCAGTCTTGG-3'. PCR products were electro-
phoresed on 3% Nusieve 3:1 agarose gel (Takara Bio Inc.)
and stained with ethidium bromide.
RNA interference
siRNAs targeting the mouse AhR gene (si-AhR) and a
scrambled siRNA (scramble) were synthesized (QIA-
GEN).These siRNAs were transiently transfected into the
cells using RNAiFect (QIAGEN) according to the manu-
facturer's instructions. Sequences of the siRNAs were as
follows: si-AhR, 5'-UCCCACAUCCGCAUGAUUATT-3'
and 5'-TTAGGGUGUAGGCGUACUAAU-3'; scramble, 5'-
UACCCAUCAUGACCCUGAUTT-3' and 5'-TTAUGGGU
AGUACUGGGACUA-3'. After transfection, the cells were
cultured in growth medium overnight, exposed to 10 nM
TCDD for 24 h, and then collected. Total RNAs were
extracted from the cells and reverse-transcribed as
described for reverse transcription (RT)-PCR protocol. The
resulting cDNAs were used in real-time PCR as templates.
Real-time PCR
Real-time PCR was performed with DNA Engine (Bio-Rad
Laboratories Inc.) using the DyNamo SYBR Green qPCR
Kit (Finnzymes, Oy, Finland). The primers were the same
as those described for RT-PCR. The PCR conditions were
as follows: 95°C for 5 min, 40 cycles of 95°C for 10 s,
58°C for 10 s, and 72°C for 20 s, with fluorescence meas-
urements read during each cycle. The expression levels of
AhR and TH mRNAs were normalized to those of cyclo-
philin mRNA.
High-performance liquid chromatography (HPLC)
The amounts of L-dopa and catecholamines (dopamine,
noradrenaline, and adrenaline) were determined using a
fluorescent HPLC method by SRL (Tokyo, Japan). Briefly,
the cells were collected and homogenized in 60%
HClO4(2.0 × 107  cells/ml). After centrifugating the
homogenates, the supernatants were collected, deriva-
tized with ethylenediamine to detect L-dopa or with
diphenylethylenediamine to detect catecholamines, and
then analyzed by HPLC using a fluorescent detector.
Immunohistochemistry
Formalin fixed paraffin embedded sections (6 μm thick)
of rat brain were obtained from Genostaff (Tokyo, Japan).
The sections were dewaxed and pretreated by microwav-
ing for 10 min in citrate buffer, pH 6.0. To detect AhR pro-
tein, the sections were treated with 3% hydrogen peroxide
in methanol for 15 min and 10% goat serum for 30 min,
and then incubated with anti-AhR mouse monoclonal
antibody (1:2500; Affinity BioReagents) overnight. After
washing with TBS, the sections were incubated withEnvironmental Health 2009, 8:24 http://www.ehjournal.net/content/8/1/24
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Histofine Simple Stain MAX PO (M) (Nichirei, Tokyo,
Japan), washed with TBS, and then visualized by DAB/
H2O2. To detect TH protein, the sections were treated with
10% goat serum for 30 min and incubated with anti-TH
rabbit polyclonal antibody (1:400; Millipore) overnight.
After washing with TBS, the sections were treated with
Biotin blocking system (Dako, Glostrup, Denmark), incu-
bated with a biotin-conjugated goat anti-rabbit IgG
(1:400; Dako), and then washed with TBS. Then, the sec-
tions were treated with AP-conjugated streptavidin,
washed with TBS, and then visualized using ALP Red
(Diagnostic Biosystems, CA, USA). For double staining,
the sections were first stained with anti-AhR antibody fol-
lowed by staining with anti-TH antibody. The sections
were counterstained with Mayer's hematoxylin and
mounted with Malinol (Mutoh Chemical Co., Tokyo,
Japan).
Construction of plasmids
Five successive fragments of the mouse TH gene 5'-flank-
ing region (-488 to +30 bp) were generated by PCR using
mouse genomic DNA as a template (Promega, WI, USA).
PCRs were performed with five distinct forward primers
and a common reverse primer, resulting in the generation
of five successive deletion constructs (-488 to +30, -375 to
+30, -285 to +30, -167 to +30, and -65 to +30 bp). Each
primer was designed to contain an additional restriction
site (KpnI or NheI) to facilitate directional cloning. The
primer sequences were as follows: forward 1 (-488 to -463
bp), 5'-cgtggtaccACATACACTGGGGCAGTGAGTAGAT-3';
forward 2 (-375 to -350 bp), 5 '-cggggtaccAGATTTATTT-
GTCTCCAAGGGCTAT-3'; forward 3 (-285 to -260 bp), 5'-
cggggtaccATTAGAGAGCTCTAGATGTCTCCTG-3'; for-
ward 4 (-167 to -142 bp), 5'-cccggtaccCTAATGGGACG-
GAGGCCTCTCTCGT-3'; forward 5 (-65 to -40 bp), 5'-
cggggtaccGTGGGGGACCCAGAGGGGCTTTGAC-3'; and
reverse (+5 to +30 bp), 5'-gcagctagcAAGCTGGTGGTC-
CCGAGTTCTGTCT-3'. Lower case letters in the sequence
indicate the restriction sites added at the 5' end of each
primer. The deletion fragments were cloned into the KpnI/
NheI site in a luciferase reporter vector PGV-B2 (Toyo-B-
Net Co. Ltd., Tokyo, Japan).
Luciferase reporter gene assay
Neuro2a cells (0.8 × 105) were cultured overnight in 24-
well plates. The next day, the cells were transiently
cotransfected with each reporter plasmid containing the
five distinct deletion fragments, pcDNA-rAhR, and
pcDNA4/V5-His/lacZ at a ratio of 2:1:1 using Lipo-
fectamine 2000(Invitrogen) according to the manufac-
turer's instructions. The plasmid pcDNA4-rAhr expressing
rat AhR was constructed previously [25]. The plasmid
pcDNA/V5-His/LacZ (Invitrogen) expressing β-galactosi-
dase was used as a transfection efficiency control. Twenty-
four hours after transfection, the cells were exposed to
DMSO or 10 nM TCDD for 24 h and then collected. Luci-
ferase assays were performed using the PicaGene LT2.0 kit
(Toyo-B-Net Co. Ltd.) according to the manufacturer's
instructions. The luciferase activities were measured using
a Mithras LB940 luminometer (Berthold Technologies,
Bad Wildbad, Germany). Luciferase activity was normal-
ized with β-galactosidase activity, based on the results of
control experiments by using of β-galactosidase and
Renilla Luc. (data not shown).
Electrophoretic mobility shift assay (EMSA)
AhR and ARNT were generated by in vitro coupled tran-
scription and translation using the TNT-coupled rabbit
reticulocyte lysate system according to the manufacturer's
instructions (Promega). Double-stranded oligonucleotide
probes were synthesized and labeled with Alexa Fluor 532
(Invitrogen). EMSA was performed using Gel Shift Kit,
second generation (Roche Diagnostics K.K, Tokyo, Japan)
according to the manufacturer's instructions. Equal vol-
umes of AhR and ARNT were premixed in the presence of
DMSO or 1 μM TCDD for 2 h at 37°C. The premixes were
incubated with labeled probes at final concentrations of
1.2 fmol/μl or 4.5 fmol/μl in the binding buffer contain-
ing poly (dI-dC) at the final concentration of 8 ng/μl for
15 min at 15°C. A competition assay was performed by
adding 200-fold molar excess of unlabeled oligonucle-
otide probes to the reaction. The DNA-protein complexes
were resolved on 6% denaturing polyacrylamide gel in 1×
Tris-borate/EDTA buffer. Subsequently, the gels were
scanned using a fluorescent scanner (Typhoon 8600; GE
Healthcare Bio-Sciences Corp., New Jersey, USA). The
sequences of the oligonucleotide probes were as follows:
C (-238 to -213 bp region of the murine TH gene), 5'-
TGTCTTCATGTCGTGTCTAGGGCGG-3'; XRE (-1029 to -
1004 bp of the murine CYP1A1 gene), 5'-CCTCCAG-
GCTCTTCTCACGCAACTCC-3'. The consensus sequence
of XRE is in bold.
Statistics
All values are presented as mean ± standard deviation
(SD). All experiments were performed at least three times.
Data were analyzed by Student's t-test using the Microsoft
Excel software package.
Results
TCDD induced TH gene expression based on AhR 
activation
In order to develop an experimental model and analyze
the relationship between AhR activation and neurotoxic-
ity, we constructed the N2a-R cell line, which is an AhR-
overexpressing cell line constructed by transfection of
Neuro2a cells with the rat AhR cDNA [25]. From the N2a-
R cell line, we obtained several clones containing N2a-Rα
and N2a-Rβ cells. In a previous report, we demonstrated
that N2a-Rα cells show hyperexpression of the TH geneEnvironmental Health 2009, 8:24 http://www.ehjournal.net/content/8/1/24
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caused by AhR activation in a ligand-independent man-
ner. For further investigation of neurotoxic phenotype
including TH gene expression by ligands, we used another
clone regarded as N2a-Rβ cells. N2a-Rβ cells express a
large amount of AhR, which acts in a ligand-dependent
manner [25]. Figure 1A shows AhR protein expression in
N2a-Rβ cells. AhR was clearly detected in N2a-Rβ cells by
Western blot analysis, but was not detected in the control
cells (N2a-Vc), which were transfected with the intact vec-
tor.
We performed RT-PCR analysis with the total RNA from
TCDD-treated and untreated N2a-Rβ cells in order to ana-
lyze the ligand dependency of exogenous AhR in N2a-Rβ
cells. We chose mRNA for CYP1A1, a typical AhR-medi-
ated gene, as a functional marker of AhR activation.
CYP1A1 mRNA was detected with specific primers in the
total RNA prepared from the TCDD treated-N2a-Rβ cells,
and was weakly detected in TCDD-untreated (DMSO)
N2a-Rβ cells (Fig. 1B). CYP1A1 mRNA was not detected in
the control cells (N2a-Vc). These results suggest that the
highly expressed exogenous AhR protein of N2a-Rβ cells
was functional and ligand-activated.
RT-PCR analysis was also performed with specific primers
for TH mRNA with the total RNA prepared from TCDD-
treated and -untreated N2a-Rβ cells. Fig. 1B shows the
expression of TH mRNA in N2a-Rβ and N2a-Vc cells.
Expression of the TH gene was weak in TCDD-untreated
(DMSO) N2a-Rβ cells. It was elevated when the N2a-Rβ
cells were treated with TCDD, as compared to the TCDD-
untreated N2a-Rβ cells. TH gene expression was detected
to a very negligible extent in N2a-Vc cells. These results
support the acceleration of TH gene expression by AhR in
a ligand-dependent manner.
To confirm TH gene induction by the AhR-mediated path-
way in the presence of TCDD, we attempted to suppress
transcription of the AhR gene in N2a-Rβ cells using RNA
interference. The siRNAs, si-AhR and scramble, were sepa-
rately transfected into N2a-Rβ cells. Two days after trans-
fection, the expression of AhR and TH mRNA was
measured by real-time quantitative PCR. AhR mRNA was
decreased by about 25% in N2a-Rβ cells transfected with
si-AhR, and the TH mRNA level was decreased by about
55%. The expression levels of the AhR and TH genes were
not affected by scramble siRNA (Fig. 2). These results
clearly indicate that the increase in TH gene expression
was induced through the AhR-mediated pathway in N2a-
Rβ cells.
Induction of TH gene by TCDD exposure inN2a-Rβ cells Figure 1
Induction of TH gene by TCDD exposure inN2a-Rβ 
cells. (A) AhR protein (96 kDa) in N2a-Rβ cells was 
detected by Western blotting using an anti-AhR antibody. 
No signal was detected in N2a-Vc cells. (B) The expression 
of TH and CYP1A1 mRNAs in N2a-Rβ cells was detected by 
RT-PCR. TH mRNA expression was induced in addition to 
CYP1A1 mRNA in TCDD-exposed N2a-Rβ cells. CYP1A1, a 
typical XRE-mediated gene, was used as a marker of AhR 
activation. TH and CYP1A1 mRNAs were not detected in 
N2a-Vc cells. Data represent triplicate experiments.
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Effect of TCDD on dopamine synthesis
TH protein is expressed and functional even if abnormal
TH gene expression induced by TCDD is involved in neu-
rotoxicity, such as abnormality of the dopamine system.
We performed Western blot analysis with a specific anti-
body recognizing TH protein to evaluate the level of
expression of TH protein in TCDD-treated N2a-Rβ cells.
As shown in Fig. 3, the expression of TH protein was
clearly elevated in the presence of TCDD. This result is
consistent with the TH mRNA data in Fig. 1B.
The functional activity of TH was analyzed by measuring
intermediary products in catecholamine biosynthesis. We
measured the amounts of L-dopa, dopamine, noradrena-
line, and adrenaline in TCDD-treated N2a-Rβ cells by
high performance liquid chromatography. TH is the rate-
limiting enzyme of dopamine synthesis, catalyzing the
production of L-dopa from tyrosine. If the expression of
TH is increased, the amount of L-dopa should increase
proportionally. The amounts of L-dopa and dopamine
were increased 1.75- and 1.59-fold, respectively, by TCDD
exposure, whereas the amount of noradrenaline was not
substantially changed. Adrenaline was not detected either
in the presence or the absence of TCDD (Table 1).
Colocalization of AhR with TH in midbrain
In our in vitro experimental model, treatment of N2a-Rβ
cells with TCDD induced functional TH protein expres-
sion and elevated dopamine synthesis in a ligand-depend-
ent manner. If these responses play an important role in
the neurotoxicity of TCDD, AhR and TH protein should
be expressed concomitantly in dopaminergic neurons in
the brain. Therefore, we studied the colocalization of AhR
and TH proteins in adult rat brain, in vivo, by immunohis-
tochemical staining of the formalin fixed paraffin embed-
ded coronal brain sections prepared from 10-week-old
rats. AhR protein was detected in the substantia nigra pars
compacta (SNc) of the midbrain, CA1–CA3 region of the
hippocampus, and the dentate gyrus (Fig. 4A). SNc con-
tains a major population of dopaminergic neurons, and
TH protein, which is a marker of dopaminergic neurons,
was mainly detected in SNc. In addition, antibody against
TH protein stained the periaqueductal gray matter and
supramammillary nucleus (Fig. 4B). These regions were
reported previously as containing dopaminergic neurons
[35,36]. To confirm the expression of AhR in the
dopaminergic neurons, double staining with anti-TH anti-
body (red) and anti-AhR antibody (brown) was per-
formed on the same tissue section (Fig. 4C). The high-
magnification (× 400) image in Fig. 4C shows that AhR
and TH proteins were colocalized in the SNc. AhR protein
was expressed concomitantly with TH protein in a specific
region of the brain that included the SNc. These results
suggest that TCDD could influence the elevation of
dopamine level through an action on AhR in the regions
of the midbrain where AhR and TH proteins were
detected.
AhR-mediated transcriptional regulation of the TH gene
The finding that TCDD increased TH gene expression in
N2a-Rβ cells makes it likely that AhR mediates this proc-
ess. AhR is involved in xenobiotic metabolism and detoxi-
fication of exogenous chemicals such as dioxins,
including TCDD, and related chemicals, as a ligand-acti-
vated transcriptional factor. In previous studies, the lig-
and-activated AhR bound the XRE motif on the enhancer
Induction of TH protein by TCDD exposure inN2a-Rβ cells Figure 3
Induction of TH protein by TCDD exposure inN2a-
Rβ cells. TH protein (56 kDa) in N2a-Rβ cells was detected 
by Western blotting using an anti-TH antibody (open trian-
gle). The expression of TH protein was increased in TCDD-
exposed N2a-Rβ cells as compared to DMSO. Lane M shows 
molecular weight markers (kDa). Data represent triplicate 
experiments.Environmental Health 2009, 8:24 http://www.ehjournal.net/content/8/1/24
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of the target gene and induced the expression of XRE-
mediated xenobiotic enzyme genes, including cyto-
chrome P450 CYP1A1, CYP1B1, and GST [18-21]. The typ-
ical XRE motifs were not reported, however, in the
identified transcriptional regulatory region of the TH
gene.
To identify the regulatory region of AhR in the promoter
region of the TH gene, we attempted to construct a
reporter gene containing the upstream region of the TH
gene. To search for a TCDD-responsive element in the TH
promoter, 488 bp of the 5'-flanking sequence of the
mouse TH gene was cloned. A series of plasmids were con-
structed containing different lengths of TH upstream
sequences fused to the luciferase gene as a reporter gene
(Fig. 5). These plasmids were transiently co-transfected
with rat AhR-expressing plasmids and β-galactosidase-
expressing plasmids as a transfection efficiency control
into intact Neuro2a cells. To investigate the responses of
TCDD corresponding to each region, we measured the
luciferase activity of cells transfected with plasmids con-
taining different lengths of TH upstream sequences. Trans-
fectants with three plasmids containing 5'-flanking
Table 1: Increase in dopamine level by TCDD exposure to N2a-Rβ cells
L-dopa and catecholamines Amount Fold increase
DMSO TCDD
L-dopa (ng/2 × 107cells) 118.8 ± 18.9 208.8 ± 18.0 1.75**
Dopamine (ng/2 × 107cells) 17.7 ± 2.7 28.1 ± 2.9 1.59**
Noradrenaline (pg/2 × 107cells) 66.8 ± 11.1 71.5 ± 8.6 1.07
Adrenaline (pg/2 × 107cells) N.D. N.D. N.D.
L-dopa and catecholamines in N2a-Rβ cells were measured by a fluorescent HPLC method. Amounts of L-dopa and dopamine were significantly 
higher in TCDD-exposed N2a-Rβ cells as compared to unexposed N2a-Rβ cells. Fold increase represents the ratios of the amounts in TCDD-
exposed cells to those in unexposed cells. No change was observed in the amount of noradrenaline with or without TCDD exposure to N2a-Rβ 
cells.
Values are mean ± SD of four replicate determinations. ND, not detected. **P < 0.01.
Localization of AhR and TH proteins in the rat brain Figure 4
Localization of AhR and TH proteins in the rat brain. 
Immunohistochemical staining with anti-AhR and/or TH anti-
bodies was performed on formalin fixed paraffin embedded 
coronal brain sections prepared from 10-week-old rats. Sig-
nals of AhR and TH proteins were developed using DAB/
H2O2 (light brown) and ALP-RED (light red), respectively. 
Sections were counterstained with hematoxylin. (A) AhR 
protein was detected in the substantia nigra pars compacta 
(SNc) in the midbrain (black arrow), hippocampus, and den-
tate gyrus. Bar = 1 mm. (B) TH protein was detected in the 
SNc (black arrow) and hypothalamic area. Bar = 1 mm. (C) 
Double staining revealed colocalization of AhR and TH pro-
teins in SNc (black arrow). Bar = 1 mm. Magnified (× 400) 
views of the SNc region were inset in each panel. Bar = 50 
μm.
TCDD-responsive region within the 5'-flanking region of the  TH gene Figure 5
TCDD-responsive region within the 5'-flanking 
region of the TH gene. A deletion construct containing 
the 5'-flanking region of the murine TH gene fused to luci-
ferase gene was generated. On the left is a schematic repre-
sentation of the deletion constructs. Numbers on each 
construct indicate distance in bp from a putative transcrip-
tion start site of the TH gene (+1). These constructs were 
transiently cotransfected into Neuro2a cells with an AhR 
expression vector (pcDNA4-rAhR) and a β-galactosidase 
expression vector (pcDNA4/V5-His/LacZ). The luciferase 
assay was performed 24 h after exposure to 10 nM TCDD. 
Relative luciferase activities were normalized with β-galactos-
idase activities. The 5'-flanking regions of the TH gene 
shorter than -167 bp did not increase luciferase activity in 
TCDD-exposed Neuro2a cells. Data are presented as mean 
± SD of three replicate determinations.
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sequences longer than 285 bp showed significant luci-
ferase activity in response to TCDD (Fig. 5). In contrast,
transfectants with two plasmids containing less than 167
bp of the 5'-flanking sequence did not induce transcrip-
tion of the luciferase gene in response to TCDD. From
these results, the TCDD-responsive element appeared be
localized in a sequence between -285 bp to -167 bp. The
sequence contains several putative and confirmed cis-act-
ing regulatory elements such as hypoxia-inducible factor-
1, AP-1, CRE, E-box, and the partial dyad element [37,38].
However, the sequence does not contain XRE. If TCDD-
activated AhR binds the sequence and affects the rate of
transcription, AhR should regulate the transcription of the
TH gene in an XRE-independent manner.
To determine whether the sequence from -285 bp to -167
bp could induce the TH gene on exposure to TCDD, EMSA
experiments were performed against the candidate
sequence. Because TCDD-activated AhR translocates into
the nucleus with ARNT and binds to DNA, EMSA was per-
formed in the presence of AhR and ARNT generated in
vitro (see Methods section). The candidate sequence, 5'
flanking sequence of the TH gene (-285 to -167 bp), was
divided into five fragments namely A, B, C, D, and E. We
determined the sequences, which bound the AhR-ARNT
complex on exposure to TCDD. Fig. 6B shows that the
AhR-ARNT complex bound to sequence C (lane 3). To
confirm whether the binding of the AhR-ARNT complex
to sequence C is unique, competitive EMSA was per-
formed using unlabeled XRE, a typical AhR-ARNT binding
element, as a competitor. As shown in Fig. 6C, formation
of the DNA-protein complex was inhibited by the XRE
competitor (lane 3). Because formation of the complex
was not observed in the absence of AhR and/or ARNT
(lanes 4 and 5), the binding of TCDD-activated AhR to
sequence C required ARNT, whereas sequence C did not
contain the consensus XRE sequence (GCGTG). There-
fore, it is likely that the elevation of TH gene expression
induced by TCDD in neural cells is regulated by a pathway
other than the AhR-XRE-mediated pathway that is used in
the xenobiotic response.
Discussion
Dioxins and related compounds cause diverse toxic
responses, including hepatocellular damage, immune sys-
tem disorders, reproductive system disorders, teratogene-
sis, carcinogenesis, and nervous system disorders [1-4].
The mechanism of actions of dioxins and related com-
pounds involves genomic control to a large extent such as
transcriptional activation. Abnormal expression of many
TCDD-responsive genes is thought to be involved in the
toxic effects of TCDD [16,17].
In a previous study, we reported that the TH gene is a
TCDD-responsive gene in neurons [25]. In this study, we
showed that TCDD not only increases TH gene expression
but also the amounts of dopamine and L-dopa in TCDD-
exposed murine neuroblastoma cells (Neuro2a) (Table
1). The result of these in vitro experiments indicates that
TCDD can disturb the equilibrium of the dopamine sys-
tem through abnormal dopamine synthesis resulting
from abnormal TH gene expression.
Experimental animal studies and epidemiological studies
indicated that TCDD and related compounds potentially
cause neurodevelopmental disabilities such as learning
Binding of the AhR-ARNT complex to the TCDD-responsive  sequence in the TH enhancer Figure 6
Binding of the AhR-ARNT complex to the TCDD-
responsive sequence in the TH enhancer. The 
sequence is obtained from the murine TH gene 5'-flanking 
region (-285 to -167 bp). Each of the five underlined 
sequences (sequences A-E) was used as a TH 5'-flanking oli-
gonucleotide probe for EMSA. (B) Alexa Fluor 532-labeled 
probes (sequences A-E) were incubated with the compo-
nents indicated above each lane. EMSA signals were detected 
using a Typhoon 8600 fluorescent scanner. Black arrow indi-
cates specific signal from the DNA-protein complex. In the 
presence of TCDD, the AhR-ARNT complex bound to 
sequence C (lane 3). (C) Using Alexa Fluor 532-labeled 
sequence C, EMSA was performed with and without unla-
beled XRE probe as a competitor. In the presence of ARNT, 
the AhR-ARNT complex bound to sequence C (lane 1). This 
signal increased on exposure to 1 μM TCDD (lane 2) and 
decreased in the presence of unlabeled XRE as a competitor 
(lane 3). Data represent triplicate experiments.
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disabilities and ADHD [10,11]. Clinical studies indicated
that neurodevelopmental disabilities such as ADHD are
closely related to the dopamine system of the midbrain. A
PET study indicated that accumulation of [18F] dopa in the
right midbrain was 48% greater in 10 children with
ADHD as compared to 10 normal children [39]. Another
PET study indicated that the [11C] dopa influx rate in the
midbrain was 17.2% lower in 8 male adolescents with
ADHD as compared to 8 normal boys [40]. A disorder of
the dopamine system of midbrain is believed to be
involved in ADHD.
The SNc, a midbrain nucleus, has abundant dopaminergic
neurons, mainly A9 neurons [35,41]. As shown in Fig. 4,
AhR, a dioxin receptor, was expressed in TH-positive neu-
rons in the SNc, as determined by immunohistochemis-
try. This indicates that dopaminergic neurons in the SNc
can be directly affected by TCDD. Briefly, it is likely that
TCDD could interfere with the adjustment of dopamine
concentration following the transactivation of the TH
gene, and consequently disturb dopamine metabolism
and/or dopaminergic neurotransmission of SNc. There-
fore, we concluded that transactivation of the TH gene is
one of the first molecular events of neurodevelopmental
disabilities after exposure to TCDD.
At the molecular level, dioxins, including TCDD, affect
gene transcription through AhR binding and successive
AhR activation. AhR is a nuclear receptor that binds to
dioxins and is a ligand-dependent transcription factor
belonging to the bHLH-PAS family [14,15]. The mecha-
nism of gene expression regulated by dioxins is not fully
understood but is usually assumed to be attributable to
the AhR-XRE-mediated reaction [16,17]. Many TCDD-
responsive genes, including those encoding phase I and II
enzymes, are upregulated through XRE in the promoter
region, to which TCDD-activated AhR binds together with
ARNT. However, we did not detect definite participation
of XRE-driven transactivation in the effect of TCDD on TH
gene expression.
Transcriptional regulation of the rat TH gene has been
well studied. Basal transcription depends on transcription
factor activity at the partial dyad element (-17 bp), CRE (-
45 bp), AP-1(-205 bp), and the dyad symmetry element (-
201 bp) [37,38]. Transcription is regulated by activity at
CRE, AP-1, and hypoxia response element 1 (HRE-1, -225
bp). We analyzed transcriptional activity induced by
TCDD in the TH promoter by deletion analysis and dem-
onstrated a region at -285 bp to -167 bp in the 5'-flanking
sequence of the TH gene that had transcriptional activity
stimulated by TCDD (Fig. 5). Because this region also con-
tains an AP-1 motif, a dyad symmetry element, and HRE-
1, as mentioned above, the identified region is important
in the transcription of the TH gene. Moreover, within this
region, we narrowed the range over which TCDD acti-
vated AhR binding in an EMSA experiment. As shown in
Fig. 6, sequence C (-238 bp to -213 bp) was shown to be
an AhR-ARNT complex binding sequence. Although for-
mation of the DNA-protein complex was inhibited by an
XRE competitor, sequence C did not contain consensus
XRE ([T/G]NGCGTG [A/C] [G/C]A; minimal consensus
core sequence GCGTG) [17], contrary to the expectation.
Recently, several studies suggested that AhR binds regula-
tory sequences differently from the consensus XRE
[42,43]. For example, the following sequences were iden-
tified: an AHRE-II sequence (CATG{N6}C [T/A]TG) in
the promoter region of CYP1A2 and aldehyde dehydroge-
nase 3A2; an AnoC sequence ([C/T]GCG [C/T]GCGC [C/
A]GC) in the promoter region of CYP1B1; and an XRE-
like sequence ([G/T] [C/A]GGG) in the promoter region
of PON-1 [42,44]. Because sequence C did not contain
every sequence, we called sequence C, "AHRE-III".
TH gene expression induced by TCDD exposure would be
regulated by AHRE-III mediated mechanism independent
of the conventional AhR-mediated pathway.
Although XRE and other motifs are rarely found together
in the promoter regions of the same gene, the mechanism
of selection for AhR binding among multiple motifs was
not investigated. According to the ontological characteri-
zation of AHRE-II-regulated genes, XRE-regulated, AnoC-
regulated [43] and AHRE-II-regulated genes showed
strong functional coherence with significant enrichment
in ion channels and transporters, unlike XRE-regulated
genes [43]. Selection of the binding sequence in promoter
regions by AhR should be related to functional selection
of AhR toxicity.
In order to investigate the relation of the AHRE-III-AhR-
mediated pathway to cell function, we performed a
genome-wide homology search with AHRE-III. One of the
results of this search indicated that AHRE-III was found at
-6769 bp of the 3'-flanking region of the Mash-2 gene
(mammalian achaete-scute homologues). Mash-2 is a
member of the bHLH transcription factor family, similar
to AhR. Members of the bHLH family are related to neural
development and differentiation and form a molecular
signaling network. For example, Hes-1 (hairy and
enhancer of split homolog 1) and Hes-5 downregulate
Mash-1 and Math-1, respectively. Mash-1 and Math-1
subsequently downregulate NeuroD and Math-2, and
finally regulate the expression of nerve-specific genes [45].
Hes-1, which is a key modulator in controlling neural pro-
liferation and differentiation, was reported to be upregu-
lated by AhR [46]. Mash-2 was also reported to be related
to neurogenesis [47]. In the neural differentiation of P19
embryonal carcinoma cells, Mash-1 and Mash-2 wereEnvironmental Health 2009, 8:24 http://www.ehjournal.net/content/8/1/24
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shown to regulate differentiation in a reciprocal manner.
Mash-2 mRNA is specifically expressed in the early phase,
whereas Mash-1mRNA is expressed in the late phase.
Therefore, we hypothesize that AhR could mediate a wide
variety of genetic controls, including the detoxification
process and neural development through transactivation,
driven or not driven by XRE. The target pathway of AhR-
mediated gene expression could be selected by cell types
based on their functions and the molecular processes that
characterize them.
Consequently, the AhR-AHRE-III-mediated pathway par-
ticipates in neural development rather than xenobiotic
metabolism or the detoxification process, and TCDD may
induce neurodevelopmental disabilities through the AhR-
AHRE-III-mediated pathway.
Conclusion
The toxicity of TCDD in the nervous system has not been
well studied. In this study, we suggest that TCDD directly
regulates the dopamine system by TH gene transactivation
via the AhR-AHRE-III-mediated pathway. The mechanism
differs from the conventional AhR-XRE-mediated path-
way and xenobiotic responses.
Concerning the neurotoxic phenotype of TCDD, this is
the first evidence of a direct correlation between abnormal
expression of the TH gene, which is an elementary process
of dopaminergic dysfunction, and AhR-mediated
genomic control transmitting TCDD action to the cells.
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